Allogeneic Myeloma Vaccine
Sponsors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Conditions
Multiple Myeloma
Phase 2
Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma
CompletedNCT01045460
Start: 2010-01-15End: 2020-06-30Updated: 2021-04-09
Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete Remission
CompletedNCT01349569
Start: 2012-01-31End: 2016-10-31Updated: 2019-01-15